Atezolizumab Approved for Stage III dMMR Colon Cancer
Episode Summary
FDA approved atezolizumab plus chemotherapy after surgery for stage III mismatch-repair-deficient colon cancer, improving three-year disease-free survival and emphasizing biomarker confirmation.